AS

Avnish Shukla

Senior Manager, External Manufacturing And Supply Chain at Prime Medicine

Avnish Shukla is a seasoned professional in the field of external manufacturing and supply chain management, currently serving as Senior Manager at Prime Medicine, Inc. since April 2022, where responsibilities include overseeing contract manufacturing organizations for genetic therapies and supplier relationship management. Prior experience includes roles at Bristol Myers Squibb, where Shukla managed commercial manufacturing for CAR-T viral vectors, and at Merck, where significant contributions involved technology transfer of vaccine manufacturing processes and operational leadership in a cGMP production unit. Additional experience spans positions at DuPont, New York University, Texas Instruments, and TransCanada, showcasing a diverse background in engineering and manufacturing operations. Shukla holds a Master of Science in Supply Chain Management from Rutgers University and a Bachelor of Science in Chemical and Biomolecular Engineering from New York University.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Prime Medicine

4 followers

Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.


Industries

Employees

51-200

Links